Fig. 3From: Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolizationWasserman type 3, modified BPH classification 3 (biurethral); AÂ T2-weighted axial baseline BÂ T2-weighted sagittal baseline; preurethral dominant hyperplasia without pedunculation; CÂ T2-weighted axial follow-up DÂ T2-weighted sagittal follow-up. Volume reduction of 76Â ml to 36Â ml (53%); IPSS 24 to 10 (58%)Back to article page